We are live on ! Find out more
ONCY

ONCOLYTICS BIOTECH INC
ONCY

Delisted

ONCY was delisted on the 4th of November, 2015.

Back to rankings

1 hedge funds and large institutions have $0 invested in ONCOLYTICS BIOTECH INC in 2016 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% less funds holding

Funds holding: 3 → 1 (-2)

100% less capital invested

Capital invested by funds: $12K → $0 (-$12K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
1
Holders Change
-2
Holders Change %
-66.67%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Stifel Financial
Stifel Financial
Missouri
-$8K
2
KWMG
King Wealth Management Group
Florida
-$4K

ONCY Hedge Fund Activity: Q2 2016 in Review

1 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in ONCOLYTICS BIOTECH INC (ONCY) for Q2 2016, worth a combined $0 — down 100% from $12K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ONCY and 0 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Stifel Financial, exiting entirely with an estimated $8K sold.

  • 1 institutional investor held ONCOLYTICS BIOTECH INC (ONCY) as of Q2 2016, down from 3 in Q1 2016.
  • Funds reported $0 of ONCOLYTICS BIOTECH INC stock for Q2 2016, down 100% quarter-over-quarter.
  • 0 funds opened new ONCOLYTICS BIOTECH INC positions in Q2 2016 and 2 closed out, a net change of -2 holders.
  • The largest ONCOLYTICS BIOTECH INC seller in Q2 2016 was Stifel Financial, an estimated $8K sold.

Based on aggregated 13F filings for Q2 2016.